Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
November 14, 2023 01:00 ET
|
Pixium Vision
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming...
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
November 09, 2023 12:58 ET
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
November 08, 2023 05:45 ET
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC and AVANIA CRO CONTRACT to GUIDE the DEVELOPMENT of TWO DRUG THERAPIES and the RETINALCAM™ IMAGE VISUALIZATION DEVICE
AMD Reports Third Quarter 2023 Financial Results
October 31, 2023 16:15 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced revenue for the third quarter of 2023 of $5.8 billion, gross margin of 47%, operating income of $224 million,...
RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
October 30, 2023 14:51 ET
|
RetinalGeniX Technologies, Inc.
Proposed patient selection process is intended to reduce the cost and improve the safety and efficacy of patient candidate selection for ocular injections
Pixium Vision annonce ses résultats financiers du premier semestre 2023 et fait le point sur ses activités
October 26, 2023 01:00 ET
|
Pixium Vision
Pixium Vision annonce ses résultats financiers du premier semestre 2023 et fait le point sur ses activités Événements ultérieurs à la période : obtention d’une avance en compte courant...
Pixium Vision announces its financial results for H1 2023 and provides update
October 26, 2023 01:00 ET
|
Pixium Vision
Pixium Vision announces its financial results for H1 2023 and provides update Post period event: Received shareholder loan of €3 million from BPIFrance and Sofinnova. Extension of the maturity of...
Pixium Vision annonce le lancement d’un processus de recherche de repreneurs
October 18, 2023 13:40 ET
|
Pixium Vision
Pixium Vision annonce le lancement d’un processus de recherche de repreneurs Paris, France, 18 octobre 2023 - 19:30 (CET) - Pixium Vision SA (Euronext Growth Paris - FR001400JX97 ; Mnemo : ALPIX)...